U.S. flag

An official website of the United States government

NM_000335.5(SCN5A):c.4783T>A (p.Phe1595Ile) AND not specified

Germline classification:
Uncertain significance (3 submissions)
Last evaluated:
Aug 22, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000183085.27

Allele description [Variation Report for NM_000335.5(SCN5A):c.4783T>A (p.Phe1595Ile)]

NM_000335.5(SCN5A):c.4783T>A (p.Phe1595Ile)

Gene:
SCN5A:sodium voltage-gated channel alpha subunit 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000335.5(SCN5A):c.4783T>A (p.Phe1595Ile)
Other names:
p.F1596I:TTC>ATC
HGVS:
  • NC_000003.12:g.38554306A>T
  • NG_008934.1:g.100367T>A
  • NM_000335.5:c.4783T>AMANE SELECT
  • NM_001099404.2:c.4786T>A
  • NM_001099405.2:c.4732T>A
  • NM_001160160.2:c.4714+69T>A
  • NM_001160161.2:c.4624T>A
  • NM_001354701.2:c.4729T>A
  • NM_198056.3:c.4786T>A
  • NP_000326.2:p.Phe1595Ile
  • NP_001092874.1:p.Phe1596Ile
  • NP_001092875.1:p.Phe1578Ile
  • NP_001153633.1:p.Phe1542Ile
  • NP_001341630.1:p.Phe1577Ile
  • NP_932173.1:p.Phe1596Ile
  • NP_932173.1:p.Phe1596Ile
  • LRG_289t1:c.4786T>A
  • LRG_289:g.100367T>A
  • LRG_289p1:p.Phe1596Ile
  • NC_000003.11:g.38595797A>T
  • NM_198056.2:c.4786T>A
  • Q14524:p.Phe1596Ile
Protein change:
F1542I
Links:
UniProtKB: Q14524#VAR_074751; dbSNP: rs199473278
NCBI 1000 Genomes Browser:
rs199473278
Molecular consequence:
  • NM_001160160.2:c.4714+69T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000335.5:c.4783T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099404.2:c.4786T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099405.2:c.4732T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160161.2:c.4624T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354701.2:c.4729T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198056.3:c.4786T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000540286Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Uncertain significance
(Oct 20, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001159838ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process)
Uncertain significance
(Aug 15, 2018)
germlineclinical testing

Citation Link,

SCV001821445Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Aug 22, 2022)
germlineclinical testing

PubMed (13)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.

Kapplinger JD, Tester DJ, Salisbury BA, Carr JL, Harris-Kerr C, Pollevick GD, Wilde AA, Ackerman MJ.

Heart Rhythm. 2009 Sep;6(9):1297-303. doi: 10.1016/j.hrthm.2009.05.021. Epub 2009 Jun 23.

PubMed [citation]
PMID:
19716085
PMCID:
PMC3049907
See all PubMed Citations (14)

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000540286.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 5 papers in HGMD, 2 are functional studies that suggest no impact on protein function. Few probands and no apparent segregations; ClinVar: VUS by GeneDx

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV001159838.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The SCN5A c.4786T>A; p.Phe1596Ile variant (rs199473278), is reported in the literature in multiple individuals affected with long QT syndrome (Christiansen 2014, Hoshi 2015, Kapplinger 2009) or atrial fibrillation (Boehringer 2014, Olesen 2012, Olesen 2011), though these studies did not report if this variant cosegregates with disease. This variant is reported in ClinVar (Variation ID: 67924) and is found in the non-Finnish European population with an overall allele frequency of 0.02% (25/125810 alleles) in the Genome Aggregation Database. The phenylalanine at codon 1596 is highly conserved and occurs in a C-terminal region of SCN5A containing other missense variants identified in individuals with Long QT syndrome (Christiansen 2014, Kapplinger 2009); however, computational analyses (SIFT: damaging, PolyPhen-2: benign) predict conflicting effects of this variant on protein structure/function. Further, while electrophysiology studies indicate the p.Phe1596Ile variant has modestly faster recovery from inactivation and slightly higher persistent current than wildtype protein, these defects are thought to be insufficient to cause disease (Hoshi 2015), and protein activity appears otherwise wildtype (Olesen 2011, Hoshi 2015). Due to limited information, the clinical significance of the p.Phe1596Ile variant is uncertain at this time. References: Boehringer T et al. SCN5A mutations and polymorphisms in patients with ventricular fibrillation during acute myocardial infarction. Mol Med Rep. 2014 Oct;10(4):2039-44. Christiansen M et al. Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2. BMC Med Genet. 2014 Mar 7;15:31. Hoshi M et al. Polygenic Case of Long QT Syndrome Confirmed through Functional Characterization Informs the Interpretation of Genetic Screening Results. HeartRhythm Case Rep. 2015 Jul 1;1(4):201-205. Kapplinger JD et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm. 2009 Sep;6(9):1297-303. Olesen MS et al. High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation. Circ Cardiovasc Genet. 2012 Aug 1;5(4):450-9. Olesen MS et al. Mutations in sodium channel beta-subunit SCN3B are associated with early-onset lone atrial fibrillation. Cardiovasc Res. 2011 Mar 1;89(4):786-93.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001821445.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (13)

Description

Variant summary: SCN5A c.4786T>A (p.Phe1596Ile) results in a non-conservative amino acid change located in the ion transport domain (IPR005821) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0001 in 248326 control chromosomes (gnomAD). This frequency is approximately equal to that expected for a pathogenic variant in SCN5A causing Arrhythmia (0.0001 vs 0.0001), allowing no conclusion about variant significance. c.4786T>A has been reported in the literature as a VUS in settings of multigene panel testing in individuals/cohorts affected with a variety of cardiac conditions such as Long QT syndrome, Atrial Fibrillation, arrhythmogenic disorders and DCM (example Kapplinger_2009, Olesen_2011-2014, Lieve_2013, Boehringer_2014, Hoshi_2015, Kaltman_2019, Marschall_2019, Mazzarotto_2020). These reports do not provide unequivocal conclusions about association of the variant with Arrhythmia/Long QT syndrome. At least two publications report experimental evidence evaluating an impact on protein function (example, Olesen_2011, Hoshi_2015). These results showed no damaging effect of this variant in current-voltage relationship, steady state inactivation and steady state activation properties relative to the WT control. Nine clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024